Context Therapeutics, Inc. (CNTX)
0.4676
-0.03
(-6.50%)
USD |
NASDAQ |
Aug 24, 16:00
0.4676
0.00 (0.00%)
After-Hours: 19:20
Context Therapeutics Shareholders Equity (Quarterly) : 38.17M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 38.17M |
| March 31, 2026 | 52.20M |
| December 31, 2025 | 60.47M |
| September 30, 2025 | 73.17M |
| June 30, 2025 | 82.54M |
| March 31, 2025 | 90.98M |
| December 31, 2024 | 95.27M |
| September 30, 2024 | 83.86M |
| June 30, 2024 | 101.10M |
| March 31, 2024 | 8.443M |
| December 31, 2023 | 11.87M |
| Date | Value |
|---|---|
| September 30, 2023 | 18.38M |
| June 30, 2023 | 24.00M |
| March 31, 2023 | 28.73M |
| December 31, 2022 | 34.76M |
| September 30, 2022 | 38.07M |
| June 30, 2022 | 41.65M |
| March 31, 2022 | 45.39M |
| December 31, 2021 | 48.27M |
| September 30, 2021 | -2.149M |
| June 30, 2021 | -1.240M |
| March 31, 2021 | -1.116M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Merck & Co., Inc. | 41.93B |
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
| Johnson & Johnson | 84.97B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 46.13M |
| Total Liabilities (Quarterly) | 7.962M |
| Debt to Equity Ratio | 0.0064 |
| Current Ratio | 5.786 |
| Net Debt Paydown Yield | -0.02% |